Begliarzade, Sema,
Beilerli, Aferin,
Sufianov, Albert,
Tamrazov, Rasim,
Kudriashov, Valentin,
Ilyasova, Tatiana,
Liang, Yanchao,
Beylerli, Ozal (2023) by improving modern
diagnostic methods. The use of screening for certain tumor
markers could complement modern
Rodkin, Stanislav,
Nwosu, Chizaram,
Sannikov, Alexander,
Tyurin, Anton,
Chulkov, Vasilii Sergeevich,
Raevskaya, Margarita,
Ermakov, Alexey,
Kirichenko, Evgeniya,
Gasanov, Mitkhat (2023) pathological conditions, including this group of diseases, are based on increased cell death
through
apoptosisRodkin, Stanislav,
Nwosu, Chizaram,
Raevskaya, Margarita,
Khanukaev, Maxim,
Bekova, Khava,
Vasilieva, Inna,
Vishnyak, Diana,
Tolmacheva, Anastasia,
Efremova, Elena,
Gasanov, Mitkhat,
Tyurin, Anton (2023) . It is characterized by various molecular–cellular events, with the main ones being
apoptosis and damage to axons
. However, despite the significance of these findings, genetic
markers for prostate cancer are not currently
Usman, M.,
Beilerli, A.,
Sufianov, A.,
Kudryashov, V.,
Ilyasova, T.,
Balaev, P.,
Danilov, A.,
Lu, H.,
Gareev, I. (2023) apoptosis, activation of epidermal growth factor
receptor signaling pathway, etc. This article summarizes
Sufianov, Albert,
Begliarzade, Sema,
Beilerli, Aferin,
Liang, Yanchao,
Ilyasova, Tatiana,
Beylerli, Ozal (2023) and treatment of lung cancer remains grim, and effective therapeutic targets and molecular
markers are urgently